0001209191-20-032947.txt : 20200529 0001209191-20-032947.hdr.sgml : 20200529 20200529163214 ACCESSION NUMBER: 0001209191-20-032947 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200528 FILED AS OF DATE: 20200529 DATE AS OF CHANGE: 20200529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Collard Craig A CENTRAL INDEX KEY: 0001363558 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37490 FILM NUMBER: 20928460 BUSINESS ADDRESS: BUSINESS PHONE: 919-678-6611 MAIL ADDRESS: STREET 1: C/O CORNERSTONE THERAPEUTICS INC. STREET 2: 1255 CRESCENT GREEN DRIVE, SUITE 250 CITY: CARY STATE: NC ZIP: 27518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sierra Oncology, Inc. CENTRAL INDEX KEY: 0001290149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: 604-558-6536 MAIL ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 FORMER COMPANY: FORMER CONFORMED NAME: ProNAi Therapeutics Inc DATE OF NAME CHANGE: 20040513 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-28 0 0001290149 Sierra Oncology, Inc. SRRA 0001363558 Collard Craig A C/O SIERRA ONCOLOGY, INC. 2150 885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 BRITISH COLUMBIA, CANADA 1 0 0 0 Stock Option (right to buy) 13.88 2020-05-28 4 A 0 10000 0.00 A 2030-05-28 Common Stock 10000 10000 D The option vests as to 1/12 of the total shares monthly, beginning on June 28, 2020, with 100% of the total shares vested and exercisable on May 28, 2021, subject to the Reporting Person's provision of service to the issuer on each vesting date. /s/ Sukhi Jagpal as attorney-in-fact for Craig A. Collard 2020-05-29